1Jerrold J. Ellner. Immunoregulation in TB: Observations and Implications. Clin Trans Science,2010,3:23-28.
2Jerrold J. Ellner. The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part II: scientific advances that may provide solutions. Clin Trans Science,2009,2:80-84.
3Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. A m J Gastroenterol,2002,97:2614-2618.
4lan RW, Keyur P, William TS, et al. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Transl Med,2007,5:33.
5Wang C, Tang J, Song W, et al. HLA and cytoklne gene polymorphisms are indepen-dently associated with responses to hepatitis B vaccination. Hepatology,2004,39:978-988.
6Rapicetta M, Ferrari C, LevreroM. Viral deteminants and host immune responses in the pathogenesis of HBV infection. J Med Virol,2002,67:454-457.
7Giedraitis V, He B, Huang WX, et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol,2001,112 146-152.
8Kiyoshi M, Kazumi SK, Yumi M, et al. Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease. Translational Research,2009,153: 91-96.
